Sign up to save your podcasts
Or
Share What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?
Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?
Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
135 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
495 Listeners
JACC This Week
170 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
886 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
291 Listeners
Frankly Speaking About Family Medicine
262 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Annals On Call Podcast
196 Listeners
JAMA Medical News
89 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Freely Filtered, a NephJC Podcast
171 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners